Stemtech Corporation (STEK)
| Previous Close | 0.0590 |
| Open | 0.0571 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0531 - 0.0617 |
| 52 Week Range | 0.0221 - 0.1029 |
| Volume | |
| Avg. Volume | 369,455 |
| Market Cap | 5.861M |
| Beta (5Y Monthly) | 1.79 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0600 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREStemtech Corporation on Track for CEO and Chairman's Goal for Growth and Global Expansion
Industry Recognition: Stemtech Ranked Top 5% in Direct Selling by 'Business for Home'" NAPLES, FL / ACCESSWIRE / April 19, 2024 / (OTCQB:STEK) Stemtech Corporation, a leader in innovative health and wellness solutions through stem cells technology, ...
- ACCESSWIRE
Stemtech Corporation Announces Darryl V. Green to Direct Company Rebranding Project
NAPLES, FL / ACCESSWIRE / April 2, 2024 / Stemtech Corporation (OTCQB:STEK), a leading company in the stem cell nutritional sector, is thrilled to announce Mr. Darryl Green will direct our Rebranding Project, marking a significant milestone in the ...
- ACCESSWIRE
Stemtech Surges Ahead: Meeting Global Demand with Innovative Stem Cell Nutraceuticals
Revolutionizing Health and Wellness Through Natural Stem Cell Release NAPLES, FL / ACCESSWIRE / March 7, 2024 / Stemtech (OTCQB:STEK), a leading provider of innovative stem cell-based nutraceuticals, announces its staggering growth in the market, ...
